• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

S100B 血清生物标志物在治疗儿童轻度创伤性脑损伤中的作用。

Role of the S100B serum biomarker in the treatment of children suffering from mild traumatic brain injury.

机构信息

Department of Neurosurgery, University Hospital of Larissa, School of Medicine, University of Thessaly, Greece

出版信息

Neurosurg Focus. 2010 Nov;29(5):E2. doi: 10.3171/2010.8.FOCUS10185.

DOI:10.3171/2010.8.FOCUS10185
PMID:21039136
Abstract

OBJECT

The aim of this study was to provide a systematic update of the current literature regarding the clinical role of the S100B serum biomarker in the initial evaluation of children who have sustained a mild traumatic brain injury (TBI).

METHODS

Searches in MEDLINE were defined with the keywords "mild TBI children S100," "mild TBI pediatric S100," and "children S100 brain injury." From the pool of obtained studies, those that had the inclusion criteria of mild TBI only or mixed types of TBI but including detailed information about groups of children with mild TBI were used.

RESULTS

Few studies were identified and fewer included more than 100 cases. The prospective studies showed that the S100B biomarker levels could be influenced by patient age and the time frame between head injury and blood sampling. Moreover, extracranial sources of S100B or additional injuries could influence the measured levels of this biomarker. A normal value of S100B in children with mild TBI could rule out injury-associated abnormalities on CT scans in the majority of reported cases.

CONCLUSIONS

The vulnerability of S100B serum levels to the influences of patient age, blood sampling time, and extracranial S100B release limits the biomarker's role in the initial evaluation of children with mild TBI. The application of S100B in pediatric mild TBI cases has an elusive role, although it could help in selected cases to avoid unnecessary head CT scans.

摘要

目的

本研究旨在对目前关于 S100B 血清生物标志物在评估轻度创伤性脑损伤(TBI)患儿中的临床作用的文献进行系统更新。

方法

在 MEDLINE 中使用关键词“儿童轻度 TBI S100”、“儿科轻度 TBI S100”和“儿童 S100 脑损伤”进行搜索。从获得的研究中,选择仅包括轻度 TBI 或混合类型 TBI 但包括详细的轻度 TBI 患儿分组信息的研究。

结果

确定的研究很少,纳入的研究中超过 100 例的研究更少。前瞻性研究表明,S100B 生物标志物水平可能受到患者年龄和头部受伤与采血时间之间时间框架的影响。此外,S100B 的颅外来源或其他损伤可能会影响该生物标志物的测量水平。大多数报告的病例中,轻度 TBI 患儿的 S100B 正常值可以排除 CT 扫描上与损伤相关的异常。

结论

S100B 血清水平易受患者年龄、采血时间和颅外 S100B 释放的影响,限制了该生物标志物在轻度 TBI 患儿初始评估中的作用。尽管 S100B 在儿科轻度 TBI 病例中的应用作用尚不明确,但它可以帮助在某些情况下避免不必要的头部 CT 扫描。

相似文献

1
Role of the S100B serum biomarker in the treatment of children suffering from mild traumatic brain injury.S100B 血清生物标志物在治疗儿童轻度创伤性脑损伤中的作用。
Neurosurg Focus. 2010 Nov;29(5):E2. doi: 10.3171/2010.8.FOCUS10185.
2
Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury.S100B和神经元特异性烯醇化酶在小儿轻度创伤性脑损伤中的诊断价值
J Neurosurg Pediatr. 2009 Oct;4(4):339-44. doi: 10.3171/2009.5.PEDS08481.
3
S100B is not a reliable prognostic index in paediatric TBI.S100B并非小儿创伤性脑损伤可靠的预后指标。
Pediatr Neurosurg. 2007;43(4):258-64. doi: 10.1159/000103304.
4
Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: results using a single (24h) time-point.使用血清S100B生物标志物预测重度创伤性脑损伤后的结果:单时间点(24小时)的结果
Resuscitation. 2009 Mar;80(3):341-5. doi: 10.1016/j.resuscitation.2008.11.021. Epub 2009 Jan 15.
5
Predictive value of neuromarkers supported by a set of clinical criteria in patients with mild traumatic brain injury: S100B protein and neuron-specific enolase on trial: clinical article.基于一组临床标准的神经标志物对轻度创伤性脑损伤患者的预测价值:试验中的 S100B 蛋白和神经元特异性烯醇化酶:临床文章。
J Neurosurg. 2013 Jun;118(6):1298-303. doi: 10.3171/2013.1.JNS121181. Epub 2013 Mar 1.
6
Model predicting survival/exitus after traumatic brain injury: biomarker S100B 24h.预测创伤性脑损伤后生存/死亡的模型:生物标志物S100B 24小时。
Clin Lab. 2011;57(7-8):587-97.
7
Serum S100B protein in early management of patients after mild traumatic brain injury.血清S100B蛋白在轻度创伤性脑损伤患者早期管理中的作用
Eur J Neurol. 2009 Oct;16(10):1112-7. doi: 10.1111/j.1468-1331.2009.02653.x. Epub 2009 May 12.
8
Serum S100B determination in the management of pediatric mild traumatic brain injury.血清 S100B 测定在儿科轻度创伤性脑损伤中的应用。
Clin Chem. 2012 Jul;58(7):1116-22. doi: 10.1373/clinchem.2011.180828. Epub 2012 Apr 23.
9
Serum S100B concentrations are increased after closed head injury in children: a preliminary study.儿童闭合性颅脑损伤后血清S100B浓度升高:一项初步研究。
J Neurotrauma. 2002 Nov;19(11):1405-9. doi: 10.1089/089771502320914633.
10
GFAP and S100B in the acute phase of mild traumatic brain injury.胶质纤维酸性蛋白和 S100B 在轻度创伤性脑损伤急性期的表达。
Neurology. 2012 May 1;78(18):1428-33. doi: 10.1212/WNL.0b013e318253d5c7. Epub 2012 Apr 18.

引用本文的文献

1
Potential Correlation Between Molecular Biomarkers and Oxidative Stress in Traumatic Brain Injury.创伤性脑损伤中分子生物标志物与氧化应激之间的潜在相关性
Int J Mol Sci. 2025 Apr 18;26(8):3858. doi: 10.3390/ijms26083858.
2
Serum S100B Level in the Management of Pediatric Minor Head Trauma: A Randomized Clinical Trial.血清 S100B 水平在儿科轻度头部创伤管理中的应用:一项随机临床试验。
JAMA Netw Open. 2024 Mar 4;7(3):e242366. doi: 10.1001/jamanetworkopen.2024.2366.
3
Early systemic insults following traumatic brain injury: association with biomarker profiles, therapy for intracranial hypertension, and neurological outcomes-an analysis of CENTER-TBI data.
创伤性脑损伤后早期全身损伤:与生物标志物谱、颅内压治疗和神经结局的关联——CENTER-TBI 数据分析。
Intensive Care Med. 2024 Mar;50(3):371-384. doi: 10.1007/s00134-024-07324-8. Epub 2024 Feb 20.
4
Navigating the Complexities of Traumatic Encephalopathy Syndrome (TES): Current State and Future Challenges.应对创伤性脑病综合征(TES)的复杂性:现状与未来挑战
Biomedicines. 2023 Nov 27;11(12):3158. doi: 10.3390/biomedicines11123158.
5
S100B Protein but Not 3-Nitrotyrosine Positively Correlates with Plasma Ammonia in Patients with Inherited Hyperammonemias: A New Promising Diagnostic Tool?S100B蛋白而非3-硝基酪氨酸与遗传性高氨血症患者血浆氨呈正相关:一种新的有前景的诊断工具?
J Clin Med. 2023 Mar 21;12(6):2411. doi: 10.3390/jcm12062411.
6
Neuroprotective Effects of Kinin B2 Receptor in Organotypic Hippocampal Cultures of Middle-Aged Mice.缓激肽B2受体在中年小鼠海马器官型培养物中的神经保护作用
Front Aging Neurosci. 2019 Jul 12;11:168. doi: 10.3389/fnagi.2019.00168. eCollection 2019.
7
Assessment of the advantage of the serum S100B protein biomonitoring in the management of paediatric mild traumatic brain injury-PROS100B: protocol of a multicentre unblinded stepped wedge cluster randomised trial.血清 S100B 蛋白监测在儿科轻度创伤性脑损伤管理中的优势评估-PROS100B:一项多中心、非盲、阶梯式楔形集群随机试验方案。
BMJ Open. 2019 May 24;9(5):e027365. doi: 10.1136/bmjopen-2018-027365.
8
An update on diagnostic and prognostic biomarkers for traumatic brain injury.创伤性脑损伤的诊断和预后生物标志物的最新研究进展。
Expert Rev Mol Diagn. 2018 Feb;18(2):165-180. doi: 10.1080/14737159.2018.1428089. Epub 2018 Jan 23.
9
A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury.血清S100B蛋白水平在创伤性脑损伤评估中的临床应用综述。
Acta Neurochir (Wien). 2017 Feb;159(2):209-225. doi: 10.1007/s00701-016-3046-3. Epub 2016 Dec 12.
10
MicroRNAs with Specific Roles in Diabetes and Psychiatric Diseases.在糖尿病和精神疾病中具有特定作用的微小RNA
Clujul Med. 2014;87(2):87-90. doi: 10.15386/cjmed-288. Epub 2014 May 30.